Literature DB >> 16360396

Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma.

José A Pereira1, Jaime Jimeno, Joana Miquel, Mar Iglesias, Asumpta Munné, Joan J Sancho, Antonio Sitges-Serra.   

Abstract

BACKGROUND: The role of central neck dissection (CND) in differentiated thyroid cancer remains controversial. This study aims at elucidating the potential benefits and drawbacks of CND associated to total thyroidectomy in papillary cancer.
METHODS: Protocols of patients undergoing total thyroidectomy and CND for papillary cancer were reviewed. The following data were recorded: macroscopic appearance of central nodes; nodes obtained at operation; number of metastatic nodes and parathyroid glands incidentally resected; metastases, age, completeness, invasiveness, size score; postoperative s-Ca; complications; and recurrences. Differences between therapeutic (gross nodal involvement) and prophylactic (no apparent node involvement) CNDs were studied.
RESULTS: Forty-three patients (mean age, 52 +/- 17 years) were studied. A mean of 8.4 +/- 6.6 nodes were resected per patient. A 60% prevalence (26/43) of presence of nodal involvement (N+) was found with no difference between low- and high-risk patients. Twenty-five (60%) patients developed transient hypocalcemia, which was associated with incidental parathyroidectomy, number of nodes resected, and thymectomy. Two patients (4.6%) developed permanent hypoparathyroidism and 3 (7%), transient vocal cord paralysis. Parathyroid glands were found in 19% of the specimens. At follow-up, there were no central neck recurrences, but 5 patients developed lateral recurrences despite treatment with I(131). All 5 patients had had therapeutic CND with 6 or more metastatic nodes obtained in the CND specimen. No lateral neck recurrences were observed after prophylactic CND or in patients with < 6 nodes involved.
CONCLUSIONS: CND prevents central neck recurrences. Morbidity of bilateral CND is significant, and its systematic implementation in the absence on gross nodal involvement requires reassessment.

Entities:  

Mesh:

Year:  2005        PMID: 16360396     DOI: 10.1016/j.surg.2005.09.013

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  86 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

Review 2.  Expert consensus statement on parathyroid protection in thyroidectomy.

Authors:  Jingqiang Zhu; Wen Tian; Zhengang Xu; Kewei Jiang; Hui Sun; Ping Wang; Tao Huang; Zhuming Guo; Hao Zhang; Shaoyan Liu; Yanjun Zhang; Ruochuan Cheng; Daiwei Zhao; Youben Fan; Xiaoxi Li; Jianwu Qin; Wenxin Zhao; Anping Su
Journal:  Ann Transl Med       Date:  2015-09

Review 3.  Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection.

Authors:  Robin M Cisco; Wen T Shen; Jessica E Gosnell
Journal:  Curr Treat Options Oncol       Date:  2012-03

Review 4.  Central lymph node dissection in differentiated thyroid cancer.

Authors:  Matthew L White; Paul G Gauger; Gerard M Doherty
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

5.  Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone.

Authors:  Jong-Lyel Roh; Jae-Yong Park; Chan Il Park
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

Review 6.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

7.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

8.  Thymectomy in central lymph node dissection for papillary thyroid cancer.

Authors:  Du-Ping Huang; Xiao-He Ye; You-Qun Xiang; Xiao-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

Review 9.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

10.  Persistent disease in patients with papillary thyroid carcinoma and lymph node metastases after surgery and iodine-131 ablation.

Authors:  Frederik A Verburg; Bart de Keizer; Marnix G E H Lam; J M H de Klerk; Cornelis J M Lips; Inne H M Borel-Rinkes; Johannes W van Isselt
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.